2269.HK vs 2M7C: Side-by-Side Comparison
Compare WuXi Biologics (Cayman) Inc. (2269.HK) and China Medical System Holdings Limited (2M7C) side by side: market cap HKD 142.15B vs EUR 2.65B, P/E 25.8 vs 13.6. Financials, growth and model signals on Bullrun.
| Metric | 2269.HK | 2M7C |
|---|---|---|
| Company | WuXi Biologics (Cayman) Inc. | China Medical System Holdings Limited |
| Country / Exchange | Hong Kong | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
| Market cap | HKD 142.15B | EUR 2.65B |
| P/E ratio | 25.8 | 13.6 |
| Dividend yield | — | 3.26% |
| Valuation model | — | — |
| Revenue (FY2025) | HKD 21.79B | EUR 8.21B |
| Revenue growth YoY | +16.7% | +9.9% |
| Net income | HKD 4.91B | EUR 1.49B |
| Gross margin | 46.0% | 71.5% |
| Diluted EPS | 1.16 | 0.62 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.